Siemens improves its angiography systems with navigation technology from St. Jude Medical

110

Siemens Healthcare has integrated the navigation technology MediGuide from St. Jude Medical into its Artis zee angiography systems. By means of magnetic targeting, MediGuide locates the catheter during cardiac interventions and projects its precise position in real-time on a previously acquired fluoroscopy image of the patient.

This technology has great potential to save radiation dose during long procedures as the patient does not need to be scanned repeatedly with the angiography system in order to track the catheter.


Siemens is the first manufacturer to integrate MediGuide Technology into its Artis zee systems to provide improved navigation of catheters during electrophysiology procedures without having to subject the patient to continuous fluoroscopy. During the intervention, a miniaturised sensor integrated into the catheter can be located by receiving electromagnetic positioning signals from the MediGuide transmitters, which are incorporated into the detector housing of the Artis zee system. The MediGuide Technology then calculates the respective position and orientation of the catheter and displays it in real-time on fluoroscopic images of the patient that were recorded earlier. To display the catheter’s position precisely, the technology also compensates for patient movement caused by respiration and heart motion.


The Heart Center Leipzig, Germany, has already performed the first interventions with Artis zee and the MediGuide Technology. “The low-radiation, precise localisation of the catheter tip onto the pre-recorded fluoroscopy image is a most impressive function, because the system is able to compensate the motion from heart beat and breathing,” said Gerhard Hindricks, director of the Rhythmology Department. “For my team and me, this is clearly the future in electrophysiology.” Christopher Piorkowski, MediGuide project team leader at the Heart Center Leipzig, added: “Our clinical experience now includes more than 50 patients. The technology will have a significant impact in the field of catheter ablation, but also for the placement of left ventricular leads for cardiac resynchronisation.”


The MediGuide Technology may provide significant benefits especially during longer interventions or examinations in the cath lab. The cardiologist no longer has to take fluoroscopic images of the patient each time the catheter is re-positioned, as is the case with current technology. As a result, less radiation and less contrast agent use is expected. “With the MediGuide Technology, we have expanded our CARE dose-reduction initiative with a critical functionality,” said Heinrich Kolem, head of the Angiography and Interventional X-ray business unit at Siemens Healthcare. “We are convinced that our customers will achieve better clinical results, especially during complex procedures, and at the same time will be able to save both dose and time.”